Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Liposomal Amphotericin B for Non-HIV Cryptococcal Meningitis
NCT02686853Phase 4Unknown
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Lipid-based Nanoparticles, Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of liposomal amphotericin b in cryptococcal meningitis. Primary endpoint: laboratory examination of cerebrospinal fluid at 4 weeks. Status: unknown.
02
Drugs
liposomal amphotericin b
03
Conditions
cryptococcal meningitis
Beyond the preview
Go deeper on NCT02686853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02686853.